FBLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fibrobiologics Inc (FBLG) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is experiencing bearish technical indicators, weak financial performance, and negative sentiment following a reverse stock split. While insider buying is a positive signal, it is outweighed by the lack of strong growth potential and negative analyst sentiment. It is better to hold off on investing in this stock for now.
The stock is showing bearish technical indicators. The MACD is negative and contracting, RSI indicates oversold conditions at 10.153, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 1.189, with significant resistance at 2.534 and above.
Insiders are buying, with a 358.82% increase in buying activity over the last month.
The recent 1-for-20 reverse stock split has negatively impacted investor sentiment and liquidity. Analysts have downgraded the stock and lowered price targets. The stock is also showing a high probability of negative price movement in the short term.
In Q4 2025, the company reported no revenue growth (0% YoY), a net income loss of -$3,244,000 (up 4.68% YoY), and a significant EPS drop of -44.44% YoY to -0.05. Gross margin remains at 0%.
Analysts have downgraded the stock to Hold from Buy, citing concerns over the reverse stock split. Price targets have been lowered, with the most recent target set at $4, down from $5.
